LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 143

Search options

  1. Book ; Online: Normas para la prevención de la transmisión de la tuberculosis en los establecimientos de asistencia sanitaria en condiciones de recursos limitados / por Reuben Granich . [et al.]

    Granich, Reuben / Binkin, Nancy J / Jarvis, William R / Simone, Patricia M / Rieder, Hans L / Espinal, Marcos A / Kumaresan, Jacob A / World Health Organization. Communicable Diseases Cluster

    2002  

    Abstract: WHO/CDS/TB/99.269 ... 51 p. ...

    Abstract WHO/CDS/TB/99.269

    51 p.
    Keywords Tuberculosis ; Cross infection ; Guidelines ; Communicable Diseases and their Control ; transmission prevention and control ; prevention and control
    Language English
    Publisher Ginebra : Organización Mundial de la Salud
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Book ; Online: Normas para la prevención de la transmisión de la tuberculosis en los establecimientos de asistencia sanitaria en condiciones de recursos limitados / por Reuben Granich . [et al.]

    Granich, Reuben / Binkin, Nancy J / Jarvis, William R / Simone, Patricia M / Rieder, Hans L / Espinal, Marcos A / Kumaresan, Jacob A / World Health Organization. Communicable Diseases Cluster

    2002  

    Abstract: WHO/CDS/TB/99.269 ... 51 p. ...

    Abstract WHO/CDS/TB/99.269

    51 p.
    Keywords Tuberculosis ; Cross Infection ; Guideline ; Communicable Diseases and their Control ; transmission prevention and control ; prevention and control
    Language English
    Publisher Organización Mundial de la Salud
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Is the global tuberculosis control strategy too big to fail?

    Granich, Reuben

    Lancet (London, England)

    2018  Volume 392, Issue 10160, Page(s) 2165

    MeSH term(s) Budgets ; Financing, Organized ; Global Burden of Disease/economics ; Humans ; Tuberculosis/economics ; Tuberculosis/prevention & control
    Language English
    Publishing date 2018-11-01
    Publishing country England
    Document type Letter
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(18)32751-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.

    Granich, Reuben / Gupta, Somya

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 71, Issue 11, Page(s) 2917–2919

    MeSH term(s) COVID-19 ; Continuity of Patient Care ; European Union ; HIV ; HIV Infections/epidemiology ; Humans ; Pandemics ; SARS-CoV-2
    Language English
    Publishing date 2020-08-12
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciaa689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Update on treatment as prevention of HIV illness, death, and transmission: sub-Saharan Africa HIV financing and progress towards the 95-95-95 target.

    Gupta, Somya / Granich, Reuben / Williams, Brian G

    Current opinion in HIV and AIDS

    2022  Volume 17, Issue 6, Page(s) 368–373

    Abstract: Purpose of review: After over 40 years, the HIV pandemic is amongst the deadliest in history - 100% fatal without treatment, HIV has infected over 84 million people, and has caused over 40 million deaths. Global HIV spending between 2000 and 2015 ... ...

    Abstract Purpose of review: After over 40 years, the HIV pandemic is amongst the deadliest in history - 100% fatal without treatment, HIV has infected over 84 million people, and has caused over 40 million deaths. Global HIV spending between 2000 and 2015 totaled over a half trillion dollars. Delays in harnessing scientific advances, including 'test and treat' and treatment as prevention of illness, death, and transmission (TasP) provide a cautionary tale applicable to other pandemics. Resource allocation has also been problematic with many highest burden countries spending less than 50% on care and treatment.
    Recent findings: Between 2002 and 2021, over $94 billion was budgeted for HIV in 40 sub-Saharan African countries, with 19 countries over $1 billion. In 2021, 8.1 million (32%) People Living with HIV (PLHIV) are still not on treatment; viral suppression data, the most important programme success indicator, is unavailable for 50% of countries. Of 19 countries with at least one billion dollars budgeted, seven have below 80% ART coverage, leaving 3.5 million (29%) of PLHIV off treatment and vulnerable to illness, death, and transmitting the virus to partners and children.
    Summary: With additional funding and improved efficiency, achieving the 95-95-95 target to diagnose 95% of all HIV-positive individuals, provide antiretroviral therapy (ART) for 95% of those diagnosed and achieve viral suppression for 95% of those treated by 2030 is feasible and the humane pathway towards ending the HIV pandemic.
    MeSH term(s) Africa South of the Sahara/epidemiology ; Child ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; Humans
    Language English
    Publishing date 2022-09-30
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2502511-9
    ISSN 1746-6318 ; 1746-630X
    ISSN (online) 1746-6318
    ISSN 1746-630X
    DOI 10.1097/COH.0000000000000761
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book: HIV, health and your community

    Granich, Reuben / Mermin, Jonathan

    a guide for action

    1999  

    Author's details Reuben Granich ; Jonathan Mermin
    Language English
    Size IX, 245 S. : Ill., graph. Darst.
    Publisher Stanford Univ. Press
    Publishing place Stanford, Calif
    Publishing country United States
    Document type Book
    HBZ-ID HT011180528
    ISBN 0-8047-3351-1 ; 978-0-8047-3351-9
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  7. Article ; Online: HIV in MSM in England and Wales: back to the drawing board?

    Granich, Reuben

    The Lancet. Infectious diseases

    2013  Volume 13, Issue 4, Page(s) 279–280

    MeSH term(s) Anti-HIV Agents/administration & dosage ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Homosexuality, Male ; Humans ; Male
    Chemical Substances Anti-HIV Agents
    Language English
    Publishing date 2013-04
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(13)70035-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa.

    Granich, Reuben / Gupta, Somya / Williams, Brian

    International journal of STD & AIDS

    2021  Volume 33, Issue 1, Page(s) 4–17

    Abstract: Human immunodeficiency virus (HIV) treatment prevents illness, death, and transmission. The 90-90-90 disease control target is only 73% of people living with HIV virally suppressed. For 2010 to 2019, we abstracted HIV funding data for 40 countries in sub- ...

    Abstract Human immunodeficiency virus (HIV) treatment prevents illness, death, and transmission. The 90-90-90 disease control target is only 73% of people living with HIV virally suppressed. For 2010 to 2019, we abstracted HIV funding data for 40 countries in sub-Saharan Africa (70% of global HIV burden and >99% of HIV burden in the region in 2018). During 2010-2019, there was ∼$52 billion funding for 40 countries (99% Africa HIV burden). Domestic funding ranged from $0 to $3.2 billion. PEPFAR funding was $32 billion (average $1.4 billion; range $0.089-4.3 billion) among 22 countries. Global Fund averaged $306 million ($1.9 million to $1.1 billion) for 40 countries. Among PLHIV, known HIV status averaged 80% (11% to 94%). ART coverage averaged 64% (9% to 90%). Viral suppression among PLHIV ranged from 8% to 87%. Of the 40 countries, 21 reported under 60% of PLHIV to be on treatment and 13 did not report viral suppression for 2018. Achieving 90-90-90 is feasible in challenging settings if resources are used efficiently. Despite the significant investment in the HIV response, many countries have not reached the 90-90-90 target. Greater attention to efficiency and prioritizing important targets will be required to end AIDS in Africa.
    MeSH term(s) Africa South of the Sahara/epidemiology ; HIV ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Health Services Accessibility ; Humans
    Language English
    Publishing date 2021-09-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1018089-8
    ISSN 1758-1052 ; 0956-4624
    ISSN (online) 1758-1052
    ISSN 0956-4624
    DOI 10.1177/09564624211042287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Treatment as prevention trials and ending AIDS: what do we know, when did we know it, and what do we do now?

    Granich, Reuben / Williams, Brian G

    Current opinion in HIV and AIDS

    2019  Volume 14, Issue 6, Page(s) 514–520

    Abstract: Purpose of review: HIV remains a significant global public health problem. Treatment as prevention of HIV and TB illness, death and transmission was proposed in 2006 as a means to end the HIV epidemic. We review the results of the treatment as ... ...

    Abstract Purpose of review: HIV remains a significant global public health problem. Treatment as prevention of HIV and TB illness, death and transmission was proposed in 2006 as a means to end the HIV epidemic. We review the results of the treatment as prevention trials.
    Recent findings: Some of the trials struggled with delivering services, however, most demonstrate that it is feasible to achieve at least the 90-90-90 target by scaling access to test-and-treat at the community level and by extension at the district or national level. Patients, if offered, will start and stay on immediate treatment even without symptoms. Community-based multidisease prevention campaigns have significant impact, especially for hard-to-reach men. Earlier treatment impacts illness and death including from HIV-associated tuberculosis. Test-and treat impacts transmission, however, some of the community cluster trials had difficulty showing an impact on incidence. Most trials showed incidence reduction in line with the level of viral suppression and suggest that achieving 95-95-95 is an important means to accelerate the end of the epidemic.
    Summary: TasP trial findings, HIV and TB program data, and PHIA study trend data will likely confirm that reaching at least 95-95-95 is both feasible and a key element in ending the epidemic.
    MeSH term(s) Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/epidemiology ; Acquired Immunodeficiency Syndrome/prevention & control ; Anti-HIV Agents/administration & dosage ; Clinical Trials as Topic ; Humans ; Tuberculosis/epidemiology ; Tuberculosis/etiology
    Chemical Substances Anti-HIV Agents
    Language English
    Publishing date 2019-09-30
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2502511-9
    ISSN 1746-6318 ; 1746-630X
    ISSN (online) 1746-6318
    ISSN 1746-630X
    DOI 10.1097/COH.0000000000000582
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic

    Granich, Reuben / Gupta, Somya

    Clinical Infectious Diseases

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #787110
    Database COVID19

    Kategorien

To top